NCT02126462View on ClinicalTrials.gov

Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

June 30, 2016

Conditions
Hookworm InfectionHookworm Disease
Interventions
BIOLOGICAL

Na-APR-1 (M74)/Alhydrogel®

BIOLOGICAL

Na-GST-1/Alhydrogel®

BIOLOGICAL

Hepatitis B vaccine

Hepatitis B vaccine co-administered with saline

Trial Locations (1)

BP: 118

Centre de Recherches Médicales de Lambaréné Albert Schweitzer Hospital, Lambaréné

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT02126462 - Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults | Biotech Hunter | Biotech Hunter